Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice
暂无分享,去创建一个
A. Salar | U. Jaeger | H. Johnsen | G. Verhoef | P. Lugtenburg | M. Schwenkglenks | R. Pettengell | F. Rossi | U. Duehrsen | C. Haioun | K. Bendall